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Abstract 
This study was carried out to observe biochemical and metabolic alteration in newly diagnosed subjects with 
essential hypertension when compared with normotensive subjects in both men and women within the age ranges 
of 31-40, 41-50 and 51-60 years. The plasma electrolytes were measured photometrically while bicarbonate was 
measured using back titration method. Other plasma analytes were measured colorimetrically. The mean value of 
plasma sodium, creatinine, urea, total cholesterol, low density lipoprotein-cholesterol, triglyceride, and 2 hour 
post- prandial were found to be significantly increased (p<0.0001) while plasma potassium, high density 
lipoprotein-cholesterol mean values were found to be significantly lowered (p<0.0001) except calcium with 
clinically significance when compared with standard. Plasma mean values of fasting blood sugar, total protein 
and albumin showed no significant changes which may be due to non involvement of renal damage effect of 
hypertension especially for plasma proteins. This work shows that incidence of essential hypertension is 
accompanied by biochemical and metabolic alteration and this can serve as a line of investigation for proper 
diagnosis and treatment. 
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1. Introduction 
The global prevalence of chronic non-communicable diseases such as hypertension is on the rise with the 
majority of the growth occurring among populations in developing countries such as Nigeria (Ntentie et al, 
2014). Hypertension is said to be a very common condition which remain undiagnosed until relatively late in its 
course, leading to variety of severe and life threatening conditions such as heart failure (Belue et al, 2009). The 
association of elevated blood pressure and metabolic abnormalities with poor cerebrovascular outcome had been 
recognized long before the concept of the metabolic syndrome became popular (Kannel, 1996).However, the 
establishment of hypertension as a component of the metabolic syndrome has enabled better insight into the 
condition and allowed for earlier detection and treatment. According to the Joint National Committee on 
prevention, detection, evaluation and treatment of high blood pressure (JNC VII, 2003), hypertension is said to 
be a systolic blood pressure(SP) of 140 mm Hg or greater, diastolic blood pressure (DP) of 90 mm Hg or greater 
and it has been estimated that over one billion people have hypertension worldwide(Kearney et al, 
2005).Researches have shown that essential hypertension is the commonest form of hypertension whose etiology 
remains unknown(Bolivar, 2013).Researches have also shown that 45-81 % of patients with hypertension have 
their hypertension uncontrolled (Persell et al, 2008) which has made it a leading cause of death; hence, there is 
need for correct and early diagnosis. Findings have shown that hypertension is more than just elevated blood 
pressure, but it is intimately associated with metabolic and physiological derangement (Schillaci et al, 
2004).Blood calcium, potassium and magnesium have been implicated in high blood pressure(Cunha et al, 2012). 
It has been discovered that there is a significant inverse correlation between serum magnesium levels and 
incidence of cardiovascular diseases (Bo and Pisu, 2008).Hypertension has been linked to dietary pattern and 
other sedentary life style with grave biochemical and metabolically consequences.  As a result of this and due to 
the fact that diagnosis and treatment of hypertension is associated with laboratory findings, this work tends to 
investigate biochemical and metabolic alteration in newly diagnosed subjects with essential hypertension and 
normotensive subject in order to assess its metabolic alteration for proper management.  
 
2. Subjects and Methods 
This investigation was cross-sectional in nature and it was carried out in the Department of Chemical Pathology, 
Wesley Guild Hospital Unit of Obafemi Awolowo University Teaching Hospital, Ile-Ife, Osun- State, Nigeria. 
The subjects involved in this study were 250 subjects with age range of 31-60 years who were attending medical 
outpatient clinic for the first time and were confirmed to be hypertensive but have not been taking drugs. 
Subjects with secondary hypertension, nursing mothers and pregnant women were excluded. Informed consent 
was obtained from the subjects after the study guidelines had been explained to them before brief clinical history 
was obtained from the subjects.250 subjects that have no history of hypertension and have not been taking 
hypertensive drugs were used as control. Blood pressure was measured on left arm by auscultatory method using 
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mercury sphygmomanometer. The individuals were made comfortable and seated at least for thirty minutes on 
the chair before measurement. After an overnight fast, blood samples were collected for biochemical analysis  
into lithium heparinized bottle which includes total cholesterol (TC), high density lipoprotein cholesterol (HDL-
C), low density lipoprotein cholesterol (LDL-C) and triglyceride(TG), electrolytes, urea, bicarbonate(HCO3-), 
total protein(TP), albumin(Alb), creatinine (Cr) and calcium(Ca2+).  Both fasting and 2hour post-prandial blood 
sugar samples were collected into fluoride oxalate bottle. The total cholesterol was determined using the 
enzymatic method (Allain et al., 1974), HDL-C was determined using the precipitation method (Grove, 1979) 
and triglyceride was determined using the enzymatic method (Esders and Michira, 1997). LDL-C was 
determined using the Freidwald’s formula (Friedwald et al., 1972). Electrolytes were analysed using flame 
photometric technique(Burtis et al,1999), urea was analysedcolorimetrically using diacetylmonoxime 
method.(Cheesbrough, 1999), bicarbonate was determined using back titration technique(Burtis et al, 1999), 
total protein and albumin  were analysed colorimetrically using biuret and bromocresol green method 
respectively(Cheesbrough, 1999)  and calcium was analysed colorimetrically (Cheesbrough, 1999).The plasma 
sugar was determined using the enzymatic method (Trinder, 1969).Both hypertensive and normotensive 
subjects’ samples were subjected to the same procedure. 
 
2.1 Statistical analysis: Results are presented as mean± SEM. Statistical significance and difference from 
control and test values evaluated by Student’s t-test. Statistical difference at probability of p <0.05 were 
considered to be significant. 
 
3. Results 
3.1. Blood pressure alteration in newly diagnosed hypertensive subjects compared with normotensive 
subjects. 
Blood pressure alteration in newly diagnose hypertensive subjects compared with normotensive subjects are 
shown in tables 1 and 2. The study involved 250 newly diagnosed  hypertensive subjects that have not being 
taking drugs of which 42% were men and 58% were women while another 250 normotensive subjects served as 
control of which 46% were men and 54% were women. The age were grouped into 3 categories(31-40, 41-50, 
51-60 years) with respective frequencies as shown in tables 1 and 2. For normotensive/hypertensive men 
subjects, the mean value for SP for the 3 age group were found to be120±1.55/147±1.24, 123±1.03/151±1.00,  
132±1.36/153±1.33 with DP of 84±2.26/99±0.85, 84±1.58/100±1.43, 82±2.04/95±0.65respectively. While SP 
mean value for normotensive/hypertensive women subjects were found to be 122±1.97/151±1.07,124±1.082 
/149±0.98, 131±1.71/161±1.51with DP of 82±1.78 /100±0.10, 83±1.78 (45) /96 ±1.50, 85±1.63 (50)/100±0.65 
according to age group. Comparing the normotensive with hypertensive in both men and women irrespective of 
the age, they were all significant (p<0.0001) (tables1and 2). 
 
3.2. Blood electrolyte, urea, creatinine, calcium, total protein and albumin alteration in newly diagnosed 
hypertensive compared with normotensive subjects. 
Blood electrolyte, urea, creatinine, calcium, total protein and albumin alteration in newly diagnosed hypertensive 
subjects compared with normotensive subjects for both men and women are shown in table 3 and 4. For  men, 
there were significant differences between the mean values  of Na+,K+ and Cr when  comparing the mean value 
of normotensive with hypertensive subjects(p<0.0001) within the age groups except Cr at age 31-40years. Also, 
there was significant difference between the mean value of Ca2+ of both normotensive and hypertensive 
clinically especially when it was compared with the standard (2.25-2.75mmol/l) (tables 3and4)  irrespective of 
the age group and sex. Alteration similar to the above is observed when normotensive women were compared 
with hypertensive women. Plasma urea level of 40% of the hypertensive subjects both male and female were 
significantly different from normotensive subjects (P<0.0001) especially between the ages 31-40 and 51-60 
years. HCO3-, TP and Alb were not statistically significant when comparing normotensive mean values with 
hypertensive mean value except HCO3- at  age 41-50years in men (27±0.29(50) /24±0.38*(40)) and 51-60years 
in women (24±0.55(50) /25±0.22*(60)  )                     
 
3.3. Blood lipid profile and sugar alteration in newly diagnosed hypertensive subjects compared with 
normotensive subjects. 
Tables 5 and 6 shows the blood lipid profile and blood sugar alteration in newly diagnosed hypertensive subjects 
compared with normotensive subjects in both men and women with respect to age groups. There were significant 
differences (p<0.0001) when the mean values of TC, LDL-C, HDL-C, TG of normotensive men subjects were 
compared with hypertensive men. 32% of the entire  male hypertensive subjects have their blood TC and FBS 
significantly different (p<0.0001) out of total 42% while 10%  which fell within the age range of 31-40 years 
showed no significant change when compared with normotensive subjects. LDL-C, HDL-C and 2HPP were 
found to be significantly different irrespective of the age range in male hypertensive subjects when compared 
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with normotensive subjects (p<0.0001) For women, there were significant difference (p<0.0001) especially in 
TC, LDL-C, HDL-C, FBS, 2HPP within all age ranges with the exception of age group 41-50 years in TC and 
FBS and 31-40 years in 2HPP (table 5). In both male and female hypertensive subjects, TG was found to be 
insignificant different in all ages under consideration except in age 31-40years in men and 41-50years in women 
when compared with normotensive. 
 
4. Discussion 
Finding from this study indicates that increase in plasma sodium (Na+) concentration, one of the major 
physiological extracellular element is associated irrespective of the age and sex with essential hypertension 
showing significant difference when compared with normotensive subject ( P<0.0001). The above finding  
support the fact that  increase in dietary salt intake usually result into increase in plasma concentration of Na+ 
accompanied by increase in blood pressure (Komiya et al, 1997). Therefore, the rise in plasma level of sodium 
may  be traced to  dietary salt  intake.(Matkovic et al. 1989) which has been implicated in stiffness of cardiac  
arteries (Sasfar et al, 2000; Simon et al, 2001). 100% of the entire test subjects in both sexes and across age 
groups had their plasma concentration of potassium  significantly  decreased  when compared with normotensive 
subjects  ( P<0.0001). The plasma K+ is inversely related to arterial blood pressure (Treasure and Ploth, 1983). It 
has been recorded that K+ has diuretic potential which could be its mechanism of reducing blood pressure, 
therefore, its decrease may be a contributing factor to the elevated blood pressure (Treasure and Ploth, 1983). 
Plasma urea level of 40% of the hypertensive subjects both male and female were significantly increased 
compared to normotensive subjects (p<0.0001) especially between the ages 31-40 and 51-60 years. This suggests, 
as supported by other findings, that plasma urea is significantly related to age, systolic and diastolic pressure 
with high incidence in men than women up to 60 years of age (Bulpitt and Breckenridge, 1976). Plasma Ca2+of 
both hypertensive and normotensive subjects showed no significance statistically but with clinical implication. 
First, the fact that both test and control subjects irrespective of sex fell below standard reference range of 2.25-
2.75mmol/l may suggest a poor dietary intake of calcium among the populace (Martinez, 1998). Secondly, raised   
plasma Na+ concentration has been linked with increased in urinary Ca2+excretion and bone turnover which 
could be another reason why plasma Ca2+ is low in hypertensive subjects apart from low dietary intake when 
compared with normotensive subjects (Wardener and MacGreger, 2002). There were significant increase in 
plasma creatinine level across the age ranges and sexes in hypertensive subjects when comparing normotensive 
with hypertensive subjects with the exception of age 31-40years that have the  mean values of 
normotensive/hypertensive to be 110±4.62/129±1.71.Though plasma creatinine concentration is age, sex and 
muscular size dependent but in heart disease like hypertension, the rate of creatinine  production is enhanced in 
the heart muscle depending on the severity of the hypertensive condition thereby account for usual increase in 
plasma concentration of creatinine in hypertensive subjects(Coresh et al, 2001) . Plasma proteins(total protein 
and albumin) and  bicarbonate(except at age 41-50years in men (27±0.29(50) /24±0.38*(40)  and 51-60years in 
women(24±0.55(50) /25±0.22*(60)) of hypertensive subjects showed no significant differences irrespective of 
age range and sex when compared with normotensive subjects which may be as a result of non involvement of 
renal damage effect of hypertension .The exceptions noticed in plasma HCO3-concentration may  have no 
clinical implication because all the values of both test and control subjects fell within the standard range(20-
30mmol/l) which further justify noninvolvement of renal damage effect of hypertension. Alterations in plasma 
lipid profile and sugar metabolism were noticed as a marker in essential hypertension (table 5 and 6). This study 
revealed that TC, LDL-C and 2HPP   mean value of hypertensive subjects were statistically increased (p<0.0001) 
while HDL-C was reduced which was in line with other findings (Demacker et al, 2000) when comparing 
normotensive with hypertensive subjects. The above significance patterns were also similar in both sexes and 
age groups in 2HPP with the exception of 2HPP (5.9±0.141/6.1±0.50) at age 31-40 years in women hypertensive 
subjects. This explains the reason why dyslipidemia is a major risk factor and biomarker in hypertension. 2HPP 
results revealed hyperglycemic condition, which usually accompany dyslipidemia and has made both 
hypertension and diabetes to be co- morbidity. 86% of the entire test subjects (both men and women) have their 
2HPP significantly different when compared with normotensive value while 44% already have their  2HPP mean 
values exceeding glucose renal threshold (10.0mmol/L or 180mg/dl) though FBS  mean value  showed no 
significant difference. This implies that 44% of the entire test subjects may have glucosuria, a condition that 
leads to end organ damage effect of hypertension if not controlled. Increase in blood glucose may have 
accounted for dyslipidemic condition which may have increase cardiac burden and eventually lead to an elevated 
blood pressure. About 90% of the entire test subjects had their lipid profile deranged which was in line other 
finding (Choudhury et al, 2014). 30% of the entire hypertensive group has their TG mean value to be significant 
increased when compared with normotensive group especially at age 31-40 years in men and 41-50 in women. 
But clinically, the difference  between the plasma  TG mean values of normotensive and hypertensive subjects 
irrespective of the sex suggest that the plasma TG concentration in hypertensive subjects may be moderately 
higher than normotensive subjects which might have consequence on the blood pressure. Since dyslipideamic 
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and hyperglycemic conditions noticed in essential hypertension has been linked to dietary style (Kahn, 2012), it 
may be speculated that whatever dietary style that will alter blood TC will also affect blood TG which eventually 
affect the blood pressure (Kahn, 2012).The prevalence of the hypertensive condition varies with age though  it is 
more prevalent in women at later age (Gordon, 2000) 
 
5. Conclusion 
From the above study, we found out that comparing normotensive subjects with newly diagnosed hypertensive 
subjects with respect to age and sex, plasma Na+, Cr, Urea, TC, LDL-C, TG and 2HPP were found to be 
significantly increased, K+, HDL-C and Ca2+ were found to be significantly decreased while FBS, TP, Alb, 
HCO3- shows no significant differences. The above observed metabolic alteration can serve as a line of 
investigation for proper diagnosis and treatment of essential hypertension.                      
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Table 1: 
Blood pressure alteration in newly diagnosed hypertensive subjects (H) compared with normotensive (N) 
subjects (men). 
 
Indices                  Age range 
     31 – 40                      41 – 50             51-60 
  Normo.  (n)     Hyper.  (n)                Normo.  (n)     Hyper.  (n)        Normo.  (n)     Hyper.  (n) 
SP    120±1.55 (30)     147±1.24 (25) *       123±1.03 (50)    151±1.00 (40) *       132±1.36 (35)   153±1.33 (40) * 
 DP    84±2.26 (30)       99±0.85 (25) *         84±1.58 (50)    100 ±1.43 (40) *        82±2.04 (35)     95±0.65 (40) *                         
Values are mean ± SEM. Significant difference between normotensive and hypertensive group by t-test 
*p<0.0001.  
Normo. = Normotensive, Hyper = Hypertensive, n = sample size, SP = Systolic blood pressure (mmHg), DP = 
Diastolic blood Pressure (mmHg). 
 
Table 2: 
 Blood pressure alteration in newly diagnosed hypertensive subjects (H) compared with normotensive (N) 
subjects (women). 
 
Indices                  Age range 
     31 – 40                      41 – 50             51-60 
  Normo.  (n)     Hyper.  (n)                Normo.  (n)     Hyper.  (n)                 Normo.  (n)     Hyper.  (n) 
SP     122±1.97 (40)      151±1.07 (35)*    124±1.082 (45)    149±0.98 (50) *       131±1.71 (50)   161±1.51 (60) * 
DP    82±1.78  (40)      100±0.10 (35) *     83±1.78(45)         96 ±1.50 (50) *         85±1.63 (50)   100±0.65 (60) *        
Values are Mean ± SEM. Significant difference between normotensive and hypertensive subjects by t-test 
*p<0.0001. Normo. = Normotensive, Hyper. = Hypertensive, n = sample size, SP =Systolic blood pressure 
(mmHg), DP =Diastolic blood pressure (mmHg). 
 
Table 3: 
Blood electrolyte, Urea, Creatinine, Calcium, Total protein, and Albumin alteration in newly diagnosed 
hypertensive (H) subjects compared with normotensive (N) subjects (men). 
Indices                  Age range 
     31 – 40                      41 – 50             51-60 
  Normo.  (n)     Hyper.  (n)                Normo.  (n)     Hyper.  (n)                 Normo.  (n)     Hyper.  (n) 
Na+    129±0.93 (30)      139±0.89 (25)*    130±0.82 (50)    142±0.60 (40) *     130±0.81  (35)   145±0.82   (40) * 
K+      4.1±0.10 (30)       3.4±0.07 (25)*     4.0±0.01 (50)      3.6 ±0.06 (40) *     4.0±0.09  (35)    3.4±0.037 (40) *  
Hco3-   24 ±0.34 (30)     23±0.38  (25)       27±0.29   (50)      24±0.38 (40) *       24±0.27  (35)     24±0.29    (40) 
Urea   3.6±0.18 (30)      4.7±0.14  (25)*    4.1±0.13  (50)      4.7±0.12 (40)         3.4±0.19  (35)    4.8±0.11   (40)* 
Cr      110±4.62 (30)    129±1.71  (25)       92±3.24  (50)       143±2.54 (40)*      108±3.76  (35)   144±2.90  (40)* 
Ca2+   2.05±0.06 (30)    2.06±0.07 (25)      1.9±0.05 (50)       1.87±2.54 (40)       2.0±0.06   (35)   1.93 ±0.05 (40) 
TP(g/l) 78±2.04 (30)    77±2.13   (25)        82±1.61  (50)        83±1.93    (40)       87±1.56    (35)   83 ±2.08   (40) 
Alb(g/l)  41±1.03 (30)   43±0.88  (25)        37±0.96  (50)        38±0.89    (40)      44±0.65    (35)    41 ±0.93   (40) 
Values are Mean ± SEM. Significant difference between normotensive and hypertensive subjects by t-test 
*p<0.0001. Na+ = Sodium (mmol/l), K+ = Potassium (mmol/l), HCO3- = Bicarbonate (mmol/l), Cr = creatinine 
(µmol/l), Ca2+ = Calcium (mmmol/l), TP = Total protein (g/l), Alb = Albumin(g/l). 
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Table 4: 
Blood electrolyte, Urea, Creatinine, Calcium, Total protein, and Albumin alteration in newly diagnosed 
hypertensive (H) subjects compared with normotensive (N) subjects (women) 
Indices                  Age range 
     31 – 40                      41 – 50             51-60 
  Normo.  (n)     Hyper.  (n)                Normo.  (n)     Hyper.  (n)        Normo.  (n)     Hyper.  (n) 
Na+   129±0.89 (40)     141±0.70 (35)*      129±0.84 (45)    145±0.71 (50) *     130±0.73  (50)   142±0.71   (60) * 
K+     4.0±0.08 (40)      3.5±0.06 (35)*      4.4±0.06  (45)     3.3 ±0.04 (50) *      4.1±0.10  (50)   3.3±0.03   (60) *  
Hco3-  24 ±0.28 (40)    24±0.26  (35)        25±0.24   (45)      25±0.22 (50) *       24±0.55  (50)    25±0.22    (60) 
Urea   3.3±0.13 (40)    4.7±0.14  (35)*      4.5±0.18  (45)       4.7±0.12 (50)       5.1±0.10  (50)    4.8±0.11   (60)* 
Cr     81±3.77  (40)     133±10.83  (35)      104±3.43 (45)      147±1.25 (50)*      93±3.16   (50)   156±2.73   (60)* 
Ca2+   1.87±0.05 (40)    1.88±0.06 (35)      2.0±0.05 (45)       1.99±0.05 (50)       2.0±0.05   (50)   1.98 ±0.05 (60) 
TP(g/l) 79±1.93  (40)   83±2.19   (35)        90±2.25  (45)       80±1.58    (50)       81±1.68   (50)    82 ±1.49    (60) 
Alb(g/l)  44±0.59 (40)   44±0.62   (35)       44±0.54  (45)       36±0.89    (50)*     38±0.85   (50)    38 ±0.85    (60) 
Values are Mean ± SEM. Significant difference between normotensive and hypertensive subjects by t-test 
*p<0.0001. Na+ = Sodium (mmol/l), K+ = Potassium (mmol/l), HCO3- = Bicarbonate (mmol/l), Cr = Creatinine 
(µmol/l), Ca2+ = Calcium (mmol/l), TP = Total protein (g/l), Alb = Albumin (g/l). 
 
Table 5:  
Blood lipid profile and sugar alteration in newly diagnosed hypertensive (H) subjects compared with 
normotensive (N) subjects (men) 
Indices                  Age range 
     31 – 40                      41 – 50             51-60 
  Normo.  (n)     Hyper.  (n)                Normo.  (n)     Hyper.  (n)        Normo.  (n)     Hyper.  (n) 
TC      4.8±0.19 (30)      5.2±0.18 (25)       4.3±0.14  (50)     5.1±0.71 (40) *      5.0±0.73  (35)    5.7±0.12   (40) * 
LDL   2.8±0.07 (30)      4.0±0.20 (25)*      1.5±0.05  (50)    3.7 ±0.15 (40) *     3.3±0.19  (35)    4.5±0.09   (40) *  
HDL  1.71±0.05 (30)    0.64±0.04 (25)*    2.04±0.04 (50)    1.15±0.05 (40) *    1.37±0.07 (35)   0.75±0.03 (40)* 
TG     0.6±0.03   (30)    1.2±0.09   (25)*     1.7±0.16   (50)   0.7±0.04   (40)       0.8±0.05  (35)    1.0±0.05   (40)* 
FBS   3.1±0.04   (30)    3.4±0.06   (25)       5.8±0.16   (50)   5.4±0.17   (40)*     4.3±3.16  (35)    6.8±1.94   (60)* 
2HPP 5.2±0.11  (30)    7.4±0.27    (25)*   6.1±0.13   (50)     8.3±0.29   (40)*     5.6±0.14   (35)   9.9 ±0.22  (40)* 
Values are Mean ± SEM. Significant difference between normotensive and hypertensive subjects by t-test 
*p<0.0001. TC = Total cholesterol (mmol/l), LDL = Low density lipoprotein (mmol/l), HDL = High density 
lipoprotein (mmol/l), TG = Triglyceride (mmol/l), FBS = Fasting blood sugar (mmol/l), 2HPP = 2hour 
postprandial (mmol/l). 
 
Table 6:  
Blood lipid profile and sugar alteration in newly diagnosed hypertensive (H) subjects compared with 
normotensive (N) subjects (women) 
Indices                  Age range 
     31 – 40                      41 – 50             51-60 
  Normo.  (n)     Hyper.  (n)                Normo.  (n)     Hyper.  (n)        Normo.  (n)     Hyper.  (n) 
TC      3.9±0.18 (40)      4.8±0.12 (35)*      5.0±0.16  (45)     5.5±0.13 (50)        4.8±0.17   (50)    5.7±0.14 (60)* 
LDL   2.3±0.09 (40)      3.6±0.19 (35)*      2.9±0.08  (45)     4.2±0.17 (50)*       2.7±0.07  (50)     4.0±0.12 (60)*  
HDL  1.2±0.09 (40)      0.71±0.03 (35)*    1.9±0.04  (45)      0.8±0.03 (50)*      1.6±0.04   (50)    1.2±0.04  (60)* 
TG     0.8±0.06 (40)      1.1±0.05   (35)      0.7±0.05  (45)      1.2±0.05 (50)*      1.1±0.05   (50)    1.2±0.05  (60)  
FBS   4.8±0.15 (40)      5.0±0.16   (35)*    5.2±0.15   (45)     5.6±0.16  (50)       5.2±0.15    (50)   8.5±0.24   (60)* 
2HPP   5.9±0.14 (40)   6.1±0.50   (35)    7.0±0.13   (45)     10.0±0.24 (50)*      7.2±0.18     (50)  10.5±0.16  (60)* 
Values are Mean± SEM. Significant difference between normotensive and hypertensive subjects by t-test 
*p<0.0001.  TC = Total cholesterol (mmol/l), LDL = Low density lipoprotein (mmol/l), HDL = High density 
lipoprotein (mmol/l), TG = Triglyceride (mmol/l), FBS = Fasting blood sugar (mmol/l), 2HPP = 2hour post 
prandial (mmol/l). 
